Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The activating transcription factor 2: an influencer of cancer progression.

Mutagenesis - 19 Dec 2019

Huebner Kerstin, Procházka Jan, Monteiro Ana C, Mahadevan Vijayalakshmi, Schneider-Stock Regine

Abstract excerpt

In contrast to the continuous increase in survival rates for many cancer entities, colorectal cancer (CRC) and pancreatic cancer are predicted to be ranked among the top 3 cancer-related deaths in the European Union by 2025. Especially, fighting metastasis still constitutes an obstacle to be overcome in CRC and pancreatic cancer. As described by Fearon and Vogelstein, the development of CRC is based on sequential...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Activating Transcription Factor 2
Share to Apoptosis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Disease Progression

Share to Epithelial-Mesenchymal Transition

Share to MicroRNAs

Share to Mutation

Share to Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 31799611
DOI: 10.1093/mutage/gez041
PMCID: PMC6923166

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The activating transcription factor 2: an influencer of cancer progression.PMID 31799611Read ↗

Overexpression of the transcription factor ATF3 with a regulatory molecular signature associates with the pathogenic development of colorectal cancerSemantic proximity Read ↗

Transcriptome-Wide Analysis and Experimental Validation from FFPE Tissue Identifies Stage-Specific Gene Expression Profiles Differentiating Adenoma, Carcinoma In-Situ and Adenocarcinoma in Colorectal Cancer ProgressionSemantic proximity Read ↗

eIF4G2-dependent translation restrains pancreatic cancer progressionSemantic proximity Read ↗

The forkhead-box family of transcription factors: key molecular players in colorectal cancer pathogenesisSemantic proximity Read ↗

Pan-cancer comprehensive analysis: The role of important PTK family genes in cancerSemantic proximity Read ↗

Role of Fra-2 in cancerSemantic proximity Read ↗

The role of the unfolded protein response in cancer progression: From oncogenesis to chemoresistanceSemantic proximity Read ↗

FOXK2 Transcription Factor and Its Emerging Roles in CancerSemantic proximity Read ↗

Colorectal cancer risk variant rs7017386 modulates two oncogenic lncRNAs expression via ATF1-mediated long-range chromatin loop.Semantic proximity Read ↗

ATF family members as therapeutic targets in cancer: From mechanisms to pharmacological interventionsSemantic proximity Read ↗

Endoplasmic reticulum stress signaling actively contributes to therapy resistance in colorectal cancerSemantic proximity Read ↗

Oncogenic ERRB2 signals through the AP-1 transcription factor to control mesenchymal-like properties of oesophageal adenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.